Core Technology
Cureverse is discovering new small molecule compounds targeting intractable diseases through its proprietary platform based on medicinal chemistry.
We have built a proprietary compound library with excellent efficacy, low toxicity, and high specificity by applying scaffold hopping technology. Additionally, we are developing optimized novel small molecule modulators for disease targets by utilizing the latest medicinal chemistry techniques such as Fragment-Based Drug Discovery (FBDD) and Differential Scanning Fluorimetry (DSF).
